Skip to Main Content

Paper Details

Leveraging state cancer registries to measure and improve the quality of cancer care: a potential strategy for California and beyond.
J Natl Cancer Inst
25
2015
CCR, Cancer, cancer
Author NameAffiliation
Robert A HiattUniversity of California San Francisco, CGT) Stanford Cancer Institute, Stanford University, University of Southern California, CA (DD) Department of Pathology and Laboratory Medicine (MH) and Institute for Population Health Improvement (KWK), University of California Davis, Rollins School of Public Health, Winship Cancer Institute, Emory University, Inc., Harvard Medical School/Dana Farber Cancer Institute
Robert A HiattUniversity of California San Francisco, CGT) Stanford Cancer Institute, Stanford University, University of Southern California, CA (DD) Department of Pathology and Laboratory Medicine (MH) and Institute for Population Health Improvement (KWK), University of California Davis, Rollins School of Public Health, Winship Cancer Institute, Emory University, Inc., Harvard Medical School/Dana Farber Cancer Institute
Dennis DeapenUniversity of California San Francisco, CGT) Stanford Cancer Institute, Stanford University, University of Southern California, CA (DD) Department of Pathology and Laboratory Medicine (MH) and Institute for Population Health Improvement (KWK), University of California Davis, Rollins School of Public Health, Winship Cancer Institute, Emory University, Inc., Harvard Medical School/Dana Farber Cancer Institute
Dennis DeapenUniversity of California San Francisco, CGT) Stanford Cancer Institute, Stanford University, University of Southern California, CA (DD) Department of Pathology and Laboratory Medicine (MH) and Institute for Population Health Improvement (KWK), University of California Davis, Rollins School of Public Health, Winship Cancer Institute, Emory University, Inc., Harvard Medical School/Dana Farber Cancer Institute
Michael HogarthUniversity of California San Francisco, CGT) Stanford Cancer Institute, Stanford University, University of Southern California, CA (DD) Department of Pathology and Laboratory Medicine (MH) and Institute for Population Health Improvement (KWK), University of California Davis, Rollins School of Public Health, Winship Cancer Institute, Emory University, Inc., Harvard Medical School/Dana Farber Cancer Institute
Deborah SchragUniversity of California San Francisco, CGT) Stanford Cancer Institute, Stanford University, University of Southern California, CA (DD) Department of Pathology and Laboratory Medicine (MH) and Institute for Population Health Improvement (KWK), University of California Davis, Rollins School of Public Health, Winship Cancer Institute, Emory University, Inc., Harvard Medical School/Dana Farber Cancer Institute
  • 1 - 6

Datasets